All In Biotech

Drug Trial Radar · NCT07817108

Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

A Phase III Randomized, Double-blind, Placebo-controlled Trial Evaluating the Vaccine Efficacy, Safety, and Immunogenicity of a Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged ≥40 Years

Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 18,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

18,000

Planned (sponsor's estimate)

Start

Jun 27, 2026

Primary completion

Oct 17, 2027

Study completion Oct 17, 2027

Sponsor

Sponsor type
Industry
Collaborators
Abogen Biosciences (Shanghai) Co., Ltd
First posted
Sep 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the vaccine efficacy, safety and immunogenicity of 2 injections (approximately 2 months apart) of ABO1108 in adults aged 40 years or above.

Conditions

  • Varicella-zoster Virus

Interventions

  • ABO1108Biological

    Formulation for injection

  • PlaceboDrug

    0.9% sodium chloride (normal saline) injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Confirmed herpes zoster incidence rate per person-year]Time frame: ≥30 days after receiving two doses of the study vaccine

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Shandong Center for Disease Control and Prevention

    Jinan, China · Recruiting

  • Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention

    Nanning, China · Recruiting

  • Hebei Province Center for Disease Control and Prevention

    Shijiazhuang, China · Recruiting

  • Zhejiang Center for Disease Control and Prevention

    Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.